Upregulated (Yang et al., 2013) miR-495 targets IGFIR and regulates ERK and AKT pathways, therefore inhibiting invasion and proliferation potential of HCC cells (Kim et al., 2012). Here, AKT1 is linked to hepatocellular carcinoma.